Clinical Data this week announced that triple-digit growth in its pharmacogenomics unit contributed to a 39-percent increase in first-quarter revenues.
The news comes one week after the company announced it had acquired Adenosine Therapeutics for up to $60 million in an effort to expand its pipeline of potential therapeutic/diagnostic combination products.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
